Our Vision

Our Vision is to enable you to extract the full value of your collaborations.

Elixir Software Ltd was founded in 2012 by a team of industry professionals with 70+yrs collective experience of driving successful projects supporting drug discovery and development. Our legacy of successful working within pharmaceuticals, agrochemicals and businesses equips our understanding of the increased value placed on collaborations between pharmaceutical and biotech companies, contract research organisations and academic laboratories, with effective communication being vital to making such partnerships work effectively.

Our Vision is to enable our partners to extract the full value of their collaborations. Workflows form the basis of our communication tools, leading to managed expectations and greater partnering insight.

We aim to set an industry standard for facile communication and collaboration monitoring designed from the workflow management needs of our partners.

Our Team

Paul Faulder . PhD

Managing Director

Paul has over a decade of experience in drug discovery research within the Biotechnology and Pharmaceutical sectors working for AstraZeneca, GlaxoSmithKline, Amgen and Tularik. With over 20 patents and publications, he has engaged and collaborated with many world class scientists across multiple global projects.

Having experienced the complexities for effective communication between collaborators, he recognised the need of scientists in teams and managers, for more efficient and transparent solutions to provide greater partnering insight. This realisation, coupled with his entrepreneurial interests, led Paul to co-found Elixir Software Limited, a company with the aim of providing high quality and cost effective IT solutions to this market.

David Grey . MBE

Advisor to the Board

David is the founder and chief of Tinsley-based diversified engineering group OSL and a senior figure within the Cutlers’ Company. David set up his first company in 1981 and has built up his business, by acquisition and organic growth, to a group of six manufacturing companies serving a global market, turning over £35 Million and employing over 400 staff. He was awarded an MBE in the 2010 New Year’s Honours List for his Services to Industry and Regeneration in Sheffield and has recently been elected to the Sheffield City Region LEP Board.

David’s wealth of experience serves mainly to provide advice and strategic direction to the Elixir Board.

Martin Harrison . PhD

Software Development Director

Martin has 15 years of software development experience in the Biotechnology and Pharmaceutical sectors including AstraZeneca, Amgen, Tularik, Protherics and Proteus Molecular Design. His activities have focussed on the integration of chemoinformatics with process management to support the design – make – test – analysis cycle of the drug discovery process. He has won numerous awards including an AstraZeneca Global Innovation Award for contributing to effective management of global drug discovery projects.

He has extensive experience in agile software development in both Scrum and Kanban environments alongside test-driven development and product owner experience. Martin is the original author and owner of both iTraX© and chemTraX© tracking solutions.

Oliver Böcking

IT Director

Oliver is a highly experienced and talented Software Engineer who has developed and implemented a number of major software systems for high-profile European clients including AstraZeneca and MAN Diesel. In addition to developing the front & back end infrastructure for the £800m Opal Property Group, his achievements include creating Deutsche Bank’s secure link into the London Stock Exchange.

With over 15 years of experience, he brings the right mixture of technical knowledge and business experience to the team.

David Hollinshead

Business Development Director

David has experience of creating innovative partnerships across academia and industry, frequently involving multiple partners and up to a value of £15m.

With a career spanning more than 25 years across academia, and pharmaceutical R&D in AstraZeneca, he has embraced synthetic and medicinal chemistry, the development of chemical technologies, and science policy shaping successful R&D. As well as overseeing medicinal chemistry programmes and implementing technology platforms, David initiated early Discovery outsourcing. His extensive knowledge from working with collaborators world-wide, and understanding of successful partnering underpins the business aims.

Contact Us

Talk to us to arrange a no obligation test drive to discover if Elixir’s sofware can help you.

If you wish to find out more about our software and how it can deliver real-world operational and commercial benefits to teams operating in your types ofoperating environments, simply fill in the form opposite and check the Test Drive option.

One of the Elixir team will then contact you shortly to action your request.

Elixir Software Ltd,
Lynwood House, Rowton Lane,
Rowton, Chester, CH3 6AT

Telephone: +44 (0)7557 640269
E-mail: enquiries@elixirsoftware.co.uk

Company Number 07740314